null

Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture

02.04.2009
Bausch & Lomb, the global eye health company, and 20/10 Perfect Vision AG, the femtosecond laser developer, have completed their transaction to form a joint venture focused on the laser vision correction industry. Financial terms were not disclosed.

The new company ¯ Technolas Perfect Vision ¯ combines the refractive eye surgery assets of both businesses, and will utilize its global service and support infrastructure to introduce new, laser-based vision correction procedures, initially focusing on treatments for presbyopia.

Technolas Perfect Vision is targeting the lucrative presbyopia market, providing clinicians with advanced excimer and femtosecond laser technology designed specifically to restore near vision in those patients who have lost the ability to visually accommodate. One of the most exciting new procedures is INTRACOR, a fast and painless intrastromal treatment that restores near vision, freeing patients from the need to wear reading glasses or multifocal contact lenses. INTRACOR has undergone the EC Conformity Assessment and now carries the CE Mark for the treatment of presbyopic hyperopes. Studies evaluating an even broader range of indications are already underway.

“These are breakthrough technologies, transforming the lifestyle of presbyopia sufferers and providing clinicians with a wonderful opportunity to attract new patients to their refractive practices.” said Dr Kristian Hohla, who will lead Technolas Perfect Vision as Chief Executive Officer.

News Media Contacts:
Name: Mike Riding
Contact: +49 89 940 04 419

Further information:

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>